Immunotherapy is known to be clinically beneficial for cancer patients and in many cases
represents the new standard of care. Because of this success, the interest in integrating …

Two major obstacles facing cancer nanomedicine are the tendency of nanoparticles to be
taken up by normal tissues and organs and the nanoparticles' inability to efficiently penetrate …

Immunotherapy is emerging as a groundbreaking cancer treatment, offering the
unprecedented opportunity to effectively treat and in several cases, even cure previously …

Immunotherapy has revolutionized oncology remarkably and gained great improvements in
cancer therapy. However, tumor immunotherapy still encounters serious challenges …

Cancer immunotherapy utilizes the immune system to fight cancer and has already moved
from the laboratory to clinical application. However, and despite excellent therapeutic …

Cancer immunotherapy is an artificial stimulation of the immune system to recognize cancer
cells and activate specific immune cells to target and attack cancer cells. In clinical trials …

Conspectus Nanomedicine holds significant potential to improve the efficacy of cancer
immunotherapy. Thus far, nanomedicines, ie, 1–100 (0) nm sized drug delivery systems …

The past decades have witnessed great progress in cancer immunotherapy, which has
profoundly revolutionized oncology, whereas low patient response rates and potential …

Cancer immunotherapy is quickly growing to be the fourth most important cancer therapy,
after surgery, radiation therapy, and chemotherapy. Immunotherapy is the most promising …

Advances in immuno‐oncology have significantly improved cancer therapy outcomes.
Unfortunately, potent responses to immunotherapy have only been achieved in subsets of …